Sort
34,240 grants matching “atherosclerosis”
Elucidating the Role of Adipokines in Mediating and Predicting HF Associated with Obesity
$803,608Chiadi E Ndumele · Johns Hopkins University · R01 · FY2020 · HL
Cardiovascular Health of Seniors and the Built Environment
$803,553Kimberly Beth Morland · Icahn School Of Medicine At Mount Sinai · R01 · FY2008 · HL
Molecular Imaging of Platelets and Oxidative Stress in Atherosclerosis
$803,397Jonathan R Lindner · Oregon Health & Science University · R01 · FY2021 · HL
iPS-derived hepatocytes for interrogation of lipid phenotypes
$803,000Daniel James Rader · University Of Pennsylvania · U01 · FY2011 · HG
HLD-mediated cholesterol efflux and plaque inflammation in MESA
$802,978Steven J Shea · Columbia University Health Sciences · R01 · FY2018 · HL
Control of Cholesterol Metabolism --Bile Acid Transport
$802,901University Of Texas Sw Med Ctr/Dallas · R01 · FY2005 · HL
Cardiopulmonary structure and function in Multi-Ethnic Study of Atherosclerosis
$802,884R Graham Barr · Columbia University Health Sciences · R01 · FY2011 · HL
Toward Diagnostics and Therapies of Molecular Subcategories of CAD
$802,881Johan M Bjorkegren · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · HL
Framingham: Inflammation, Genes &Cardiovascular Disease
$802,666Boston University Medical Campus · R01 · FY2005 · HL
Integrative genomic and functional genomic studies to connect variant to function for CAD GWAS loci
$802,473Hanrui Zhang · Columbia University Health Sciences · R01 · FY2023 · HL
IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
$802,379Loren D Erickson · University Of Virginia · R01 · FY2023 · AI
IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
$802,379Loren D Erickson · University Of Virginia · R01 · FY2024 · AI
CyTOF Mass Cytometer
$802,350Shane P Crotty · La Jolla Institute For Immunology · S10 · FY2014 · OD
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS
$802,177Gerardo Heiss · Univ Of North Carolina Chapel Hill · N01 · FY2021 · HL
Framingham Project/O'Donnell
$802,164Christopher O'Donnell · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Inflammation-resolution impairments in aging and atherosclerosis
$802,138Gabrielle Fredman · Albany Medical College · R01 · FY2023 · HL
Framingham: Inflammation, Genes &Cardiovascular Disease
$802,013Boston University Medical Campus · R01 · FY2004 · HL
Prospective Evaluation of Antiviral Therapy and Cardiac Health
$801,848Judith S. Currier · University Of California Los Angeles · R01 · FY2011 · HL
Role of Smooth Muscle Cell Insulin Resistance and Systemic Metabolic Dysfunction in Atherosclerosis Development and Late Stage Lesion Pathogenesis
$801,758Gary K Owens · University Of Virginia · R01 · FY2025 · HL
Role of Smooth Muscle Cell Insulin Resistance and Systemic Metabolic Dysfunction in Atherosclerosis Development and Late Stage Lesion Pathogenesis
$801,758Gary K Owens · University Of Virginia · R01 · FY2023 · HL
Identifying Early Intervention Targets for Reducing Cardiovascular Risk in Posttraumatic Stress
$801,736Jennifer A Sumner · University Of California Los Angeles · R01 · FY2021 · HL
HDL Proteins and Coronary Heart Disease
$801,672Frank M Sacks · Harvard School Of Public Health · R01 · FY2016 · HL
Elucidating the Biology of Cardiovascular Risk in Hemodialysis Patients Using Proteomics
$801,559Ruth Dubin · Ut Southwestern Medical Center · R01 · FY2022 · HL
Control of Cholesterol Metabolism --Bile Acid Transport
$801,514John M. Dietschy · Ut Southwestern Medical Center · R01 · FY2007 · HL
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS
$801,480Josef Coresh · Johns Hopkins University · N01 · FY2018 · HL